Net Loss Per Share (Tables)

3 Months Ended

Mar. 31, 2022

Income Statement [Abstract]

Schedule of Anti-dilutive Securities Excluded from Computation of Diluted Net Loss Per Share

The following common stock equivalents were excluded from the computation of diluted net loss per share for the periods presented because including them would have had an anti-dilutive effect:

	March 31,
	2022		2021
Employee stock options issued and outstanding		9,139,344		4,475,799
Series A Common Stock Equivalent Convertible Preferred Stock		2,500,000		-
Common stock subject to the Company’s right of repurchase		1,677,569		3,212,190
SVB Warrant		-		129,156
Series Seed convertible preferred stock		-		6,520,790
Series A convertible preferred stock		-		12,932,429
Series B convertible preferred stock		-		19,373,169
Total		13,316,913		46,643,533